Staphylococcus capitis EPK1 produces a glycylglycine endopeptidase, ALE-1 (M. Sugai, T. Fujiwara, T. Akiyama, M. Ohara, H. Komatsuzawa, S. Inoue, and H. Suginaka, J. Bacteriol. 179:1193-1202, 1997), which hydrolyzes interpeptide pentaglycine chains of cell wall peptidoglycan of S. aureus. Characterizations of the enzyme activity and cloning of ale-1 revealed that ALE-1 is very similar to prolysostaphin produced by S. simulans bv. staphylolyticus. Strain EPK1 is resistant to lysis by ALE-1 and by lysostaphin. A gene that renders the cells resistant to glycylglycine endopeptidase (epr) was found 322 bp upstream of and in the opposite orientation to ale-1. The deduced amino acid sequence of epr showed similarities to FemA and FemB, which have been characterized as factors essential for methicillin resistance of S. aureus. Inactivation of either femA or femB causes decreased resistance to methicillin, increased resistance to lysostaphin, and decreased glycine content in the interpeptide chains of peptidoglycan. Therefore, femAB is suggested to be involved in the addition of glycine to pentapeptide peptidoglycan precursor. S. aureus with epr on a multicopy plasmid had phenotypes similar to those of femAB mutants except that it did not alter resistance level to methicillin. These results suggest that epr and femAB belong to the protein family involved in adding amino acids to the pentapeptide peptidoglycan precursor and that epr is involved in the addition of serine to the pentapeptide.
vancomycin were from Sigma Chemical Co., St. Louis, Mo. Lysostaphin was further purified to homogeneity before use as described previously (50) . ALE-1, 51-kDa endo-␤-N-acetylglucosaminidase (GL), and 62-kDa N-acetylmuramyl-Lalanine amidase (AM) were purified to homogeneity from the culture supernatant of S. capitis EPK1 (51) or S. aureus FDA209P (52, 53) as described previously. EXPRE 35 S 35 S protein labeling mix (1,000 Ci/mmol) was purchased from DuPont-NEN Research Products, Boston, Mass. Other materials and chemicals used were from commercial sources.
Assay for endopeptidase resistance. Exponentially growing bacterial cells in TSB were cultured in TSB containing either lysostaphin or ALE-1 with standing at 37°C to analyze the endopeptidase resistance of the cells. To determine the endopeptidase resistance level, small portions (10 6 CFU) of exponentially growing culture were added to serial twofold dilutions of either lysostaphin or ALE-1 in TSB (150 l) in two steps on a microtiter plate (Becton Dickinson and Co.).
The endopeptidase concentration was within the range of 0.05 to 500 g/ml. The plates were incubated at 37°C for 16 h, and the MICs of endopeptidases were determined by monitoring cell growth through observation of the well bottoms.
MIC and population analysis. MICs of methicillin and vancomycin were determined by a microdilution method as described previously (25) except that in some cases the incubation time was 48 h instead of 24 h. To determine the resistance level to methicillin more precisely, population analysis profiles were determined as described previously (38) . Briefly, aliquots of overnight culture (10 9 CFU) were plated on tryptic soy agar containing various concentrations of methicillin (from 0.5 to 1,024 g/ml), and colonies were counted after a 48-h incubation at 37°C. DNA manipulations. Routine DNA manipulations, DNA digestion with restriction enzymes, DNA ligations, gel electrophoresis, Southern blotting of DNA and hybridization, and DNA sequencing were performed essentially as described This study 100 0. 2  1  1  TF2  RN4220 pTFS3  This study  -50  --TF3  RN4220 pTFS31  This study  -100  --TF4  RN4220 pTFS32  This study  -100  --TF5  RN4220 pTFS33 This study -0. (39, 46, 51) . Purification of chromosomal DNA from staphylococcal cells was performed as described previously (51), with modification as follows. To lyse staphylococcal cells, lysostaphin (120 g/ml) and mutanolysin (60 g/ml) were used instead of lysostaphin alone for coagulase-negative staphylococci. Hybridization was performed by means of an enhanced chemiluminescence (ECL) procedure (ECL direct labeling kit or 3Ј-oligolabeling kit; Amersham Life Science, Buckinghamshire, United Kingdom). DNA sequences of both strands were determined by the dideoxy-chain termination method (40) with an AutoRead sequencing kit (Pharmacia Biotech, Tokyo, Japan). A nested set of deletions for sequencing was constructed by using exonuclease III and mung bean nuclease (Takara Kilosequence deletion kit; Takara Biomedicals, Tokyo, Japan) according to the method of Henikoff (18) . PCR. PCR reagents were from Perkin-Elmer (Norwalk, Conn.), and PCR was performed with the GeneAmp PCR System 2400 (Perkin-Elmer). Primers were supplied by Greiner Japan Co. (Tokyo, Japan). To generate PCR fragments containing the entire epr gene with the putative promoter region, the following primers were used: 5Ј-AAATTTAAACCTCCTAATA-3Ј and 5Ј-GCCAGCTTG TTGGGATACTC-3Ј. The amplified fragment was cloned into pCR2.1 vector by using an Original TA Cloning kit (Invitrogen Co., San Diego, Calif.). The cloned DNA fragment was checked by DNA sequencing, cut with EcoRI, and cloned into the EcoRI site of pGC2. To generate PCR fragments containing a portion of epr, the following primers were used: 5Ј-TCCAATTATCCAAAACTGA-3Ј and 5Ј-TTTTGTAAATAAAGGGTCTAA-3Ј. The amplified fragment was purified and used as the probe for Southern hybridization.
Transformation of S. aureus by electroporation. For transformation of S. aureus, S. aureus RN4220 was used as the primary acceptor for recombinant plasmid. Exponentially growing cells of S. aureus were harvested at an optical density at 660 nm of 0.6, washed twice, resuspended in 1/100 volume of ice-cold 0.5 M sucrose, and kept on ice for 15 min. To 0.04 ml of cell suspension was added 0.1 to 0.2 g of plasmid DNA. A pulse of 25 F and 2.2 kV was delivered by an Electro Cell Manipulator 600 (BTX Electroporation system, BTX Inc., San Diego, Calif.). The cells were spread on selective tryptic soy agar containing chloramphenicol (50 g/ml). The recombinant plasmid was subsequently transduced from the transformant by phage 80␣ (47) to the appropriate recipient strain as described previously (2) .
In vitro transcription and translation. In vitro synthesis of proteins from plasmid DNA templates was performed by using the Linked T7 transcriptiontranslation system (Amersham Life Science) with EXPRE 35 S 35 S protein labeling mix according to the manufacturer's protocol.
Amino acid analysis of peptidoglycan. Peptidoglycan was isolated as described previously (11) . Samples for amino acid analysis were prepared by hydrolyzing peptidoglycan with 4 N HCl at 100°C for 15 h. Samples were then analyzed by an L-8500 amino acid analyzer (Hitachi Ltd., Tokyo, Japan) with ninhydrin detection.
Susceptibility of heat-inactivated cells to bacteriolytic enzymes. The susceptibility of heat-inactivated cells to bacteriolytic enzymes was tested by zymography (24) using sodium dodecyl sulfate-polyacrylamide gel electrophoresis on polyacrylamide gels containing heat-inactivated staphylococci (0.5 mg [dry weight] of cells/ml) (28, 49) . Lysostaphin, 51-kDa GL, and 62-kDa AM were used as bacteriolytic enzymes. To detect their activities, 15% gels were used for lysostaphin and 62-kDa AM, and a 7.5% gel was used for 51-kDa GL. Ten microliters of serially diluted enzyme sample was applied to the wells. After electrophoresis, the gels were washed with distilled water for 30 min with constant agitation and incubated at 37°C in 0.1 M sodium phosphate buffer (pH 6.8).
After a 12-h incubation, visible bands were detected with an immunoviewer, and the minimal concentration that showed a visible band was defined as the minimal bacteriolytic dose (MBD) (24) .
Nucleotide sequence accession number. The nucleotide sequence data presented in this report will appear in the DDBJ, EMBL, and GenBank nucleotide sequence database under accession no. AB000222.
RESULTS
Cloning of the epr gene. DeHart et al. reported that epr is encoded very close to the gene for lysostaphin in S. simulans bv. staphylolyticus (9) . Both were shown to reside on an 8.4-kbp fragment. While cloning a gene for ale-1 in S. capitis EPK1, we obtained a 3.5-kbp HincII fragment containing ale-1 and cloned it into pUC19 to generate pTF3 (51) . We tried to determine whether the fragment contained epr. Thus, the 3.5-kbp HincII fragment of pTF3 was cloned into the HincII site of shuttle vector pGC2 to generate pTFS3. pTFS3 was transferred into S. aureus RN4220 by electroporation, transformants were selected for chloramphenicol resistance, and one isolate was designated TF2. Similarly, RN4220 carrying pGC2 was obtained as a control and designated as TF1. MICs of lysostaphin for TF2 and TF1 were determined. As shown in Table 1 , TF2 was more resistant to lysostaphin than TF1. When TF2 was spread on brain heart infusion agar containing heat-killed S. aureus FDA209P and incubated at 37°C for 24 h, all colonies of TF2 were surrounded by halos due to the lysis of S. aureus FDA209P, while no halos were observed around the colonies of TF1. This result indicated that TF2 produced and secreted ALE-1 extracellularly. On the other hand, attempts to express ALE-1 in S. aureus by transformation with pGC2 containing ale-1 alone were not successful (not shown). This result further indicated that TF2 became resistant to glycylglycine endopeptidase. A restriction map of the 3.5-kbp HincII fragment was established (Fig. 1) . To determine the minimum amount of DNA required for the endopeptidase resistance, several transformants with subcloned DNA fragments of the 3.5-kbp HincII fragment were generated. Deletions of the 3.5-kbp HincII fragment, 3.2-, 2.5-, and 2.3-kbp HincII-EcoRI fragments, and 2.2-kbp HincII-HindIII fragment were cloned into pGC2 to generate pTFS31, pTFS32, pTFS33, and pTFS34, respectively. These plasmids were then transferred into RN4220 by electroporation, and transformants were designated TF3, TF4, TF5, and TF6, respectively. Assays to deter- mine the MIC of lysostaphin revealed that TF3 and TF4 expressed endopeptidase resistance whereas TF5 and TF6 did not (Table 1) . Fragments expressing endopeptidase resistance were sequenced by using either the universal or the reverse sequencing primer. The nucleotide sequencing revealed two potential new open reading frames (ORFs), orf1 and orf2, which were in the same transcriptional direction but on different frames (Fig. 1) . The ale-1 ORF was on the opposite DNA strand to orf1. These findings suggested that the 5Ј flanking region of the 2.2-kbp HindIII-HincII DNA fragment is necessary for an endopeptidase resistance phenotype whereas orf2 is not necessary. A 1.7-kbp EcoRI-NheI fragment from insert DNA of pTF32 was subcloned into pGC2 to obtain pTFS5. The plasmid was transferred into RN4220 by electroporation, and the transformant was designated TF7. An assay to determine the MIC of lysostaphin revealed that TF7 was highly resistant to endopeptidase (Table 1) . Therefore, we designed a primer set for amplifying the DNA fragment containing all of orf1 and the flanking DNA region which contains the putative promoter sequence, as described later. PCR products were cloned into pCR2.1 in E. coli XL1-Blue and then subcloned into pGC2 to obtain pTFS6. The plasmid was transferred into RN4220 by electroporation, and the transformant was designated TF8. An assay to determine the MICs of lysostaphin revealed that TF8 was highly resistant to lysostaphin as well as ALE-1 (Table 1) , and orf1 was thus designated epr.
Nucleotide sequence of epr. Figure 2 shows the nucleotide sequence of the 2.5-kbp DNA fragment in pTFS32. epr starts with an ATG codon at nucleotide 426 and ends with a TGA codon at nucleotide 1665. A Shine-Dargarno sequence, AAA GTCG, which is similar to those of S. aureus in showing canonical homology with 16S RNA of Bacillus subtilis (32) , was observed eight nucleotides upstream of the putative start codon. A possible candidate for a promoter sequence was present upstream of the epr ORF. The sequences TTTCACA (positions 194 to 199) and TATTATT (positions 217 to 223) might be Ϫ35 and Ϫ10 promoter regions, respectively. In the region between epr and ale-1, two palindromic sequences were identified. In the region downstream of epr, we found a stemloop structure followed by multiple thymidine residues, resembling a rho-independent termination region. epr can code for a 413-amino-acid polypeptide with a calculated molecular weight of 48,990. The entire protein has a predicted isoelectric point of 9.93. In vitro protein labeling experiments using pTFS6 were carried out. The product of pTFS6, which was not found in pGC2, in the in vitro system was a protein band with an M r of 46,000, comparable to the molecular weight of the protein encoded by epr (data not shown).
When the nucleotide and deduced amino acid sequences of epr were compared with those in databases in the BLAST and FASTA network search service (DDBJ), a strong similarity was found with the amino acid sequences of FemA and FemB of S. aureus (3) (accession no. M23918). When the protein sequences of FemA and FemB were aligned with that of Epr, we found identity at 162 positions (36%) with FemA and identity at 149 positions (33%) with FemB of the total 413 amino acid residues of Epr. The hydropathy plots of these proteins are strikingly similar (not shown).
Amino acid composition of cell walls of strains with or without epr expression. To determine whether the presence of epr caused an alteration in peptidoglycan structure, peptidoglycan was isolated from S. capitis EPK1, S. capitis EPK2 (a derivative of strain EPK1 lacking a plasmid containing ale-1), S. aureus TF1, and S. aureus TF8, and then the amino acid compositions were compared. As shown in Fig. 3 , a relative decrease of serine and an increase of glycine in the molar ratio were observed in EPK2 compared with EPK1. On the other hand, TF8 had fewer glycines and more serines than TF1.
Bacteriolytic enzyme susceptibility of heat-inactivated cells. The lysostaphin-resistant phenotype and changes in amino acid composition of peptidoglycan of TF8 strongly suggested that the presence of epr altered the amino acid composition of cross bridges in S. aureus peptidoglycan. To elucidate the effect of epr overexpression on peptidoglycan, we further analyzed the cell wall structure by determining susceptibilities to various bacteriolytic enzymes with different bond specificities, including lysostaphin, 51-kDa GL, and 62-kDa AM, by using zymography as described in Materials and Methods. These enzymes are known to cleave Gly-Gly (22), GlcNAc-MurNAc (52), and MurNAc-Ala (53) bonds, respectively, in the peptidoglycan structure of S. aureus. Zymography is a highly sensitive method for detecting bacteriolytic enzymes (28, 49, 55) and is especially useful for enzymes, such as 51-kDa GL or 62-kDa AM, with lytic activity toward S. aureus unmeasurable by conventional turbidimetry without using a large quantity of the enzyme (53) . When TF8 cells were used as the substrate for zymography, the MBD of lysostaphin was eight times higher than that when TF1 was used as the substrate (Table 3) . On the other hand, MBDs of 51-kDa GL and 62-kDa AM in the TF8-containing gel were similar to those in the TF1-containing gel (Table 3) . When comparing the results of susceptibility to lysostaphin, we found the difference in MBDs between cells with and without epr to be less than the difference in MICs. This might be due to the difference in assay systems.
Hybridization. The findings of the protein homology search of epr suggested that S. capitis EPK1 contains a gene closely related to femAB. S. aureus strains with inactivated femA or femB exhibited lysostaphin resistance and decreased glycine content of cross bridges (3, 19, 26, 30, 48) . In contrast, in S. capitis EPK1 and S. aureus carrying a plasmid containing epr, glycine content was decreased and serine content was increased. This result suggested that epr and femAB belong to the same gene family but have distinct functions. A lysostaphinresistant phenotype is prevalent in coagulase-negative staphylococci (62), and its relationship to substitution of glycine residues with serine in interpeptide chains of peptidoglycan has been suggested (43, 61) . Therefore, we screened DNAs from various Staphylococcus species, including S. aureus and several coagulase-negative staphylococci, by using a probe generated by PCR. This probe represented the DNA encoding a portion of epr between the designed primers as described in Materials and Methods. The findings obtained from 26 strains are shown in Fig. 4 . This probe hybridized to an 8.3-kbp EcoRI fragment of S. capitis EPK1 and to similar-size fragments in strains of other coagulase-negative staphylococci. Variations in molecular mass of the DNA fragment hybridizing with the probe were observed in several strains. In S. capitis EPK1, the probe weakly hybridized to DNA fragments with molecular masses of less than 8.3 kbp. Loss of the 8.3-kbp EcoRI fragment in S. capitis EPK2, which is devoid of a plasmid carrying epr and ale-1, suggests that epr was present only on the plasmid. To our surprise, the probe hybridized to a fragment the same size as the 8.3-kbp EcoRI fragment of S. capitis EPK1 in S. aureus strains, although it did not hybridize to a DNA fragment containing the femAB region.
Effect of overexpression of epr in S. aureus on susceptibility to methicillin and vancomycin. femA and femB were initially identified as genes essential for methicillin resistance in methicillin-resistant S. aureus (MRSA) (3). Transposon mutagenesis of either femA or femB increased the susceptibility of methicillin-susceptible S. aureus (MSSA) and MRSA to methicillin, and this sensitization effect was markedly apparent in MRSA (3, 19, 30) . These mutants showed increased resistance to lysostaphin, decreased glycine content, and a slight increase in serine content in the peptidoglycan cross bridges (19, 30) . On the other hand, S. haemolyticus strains expressing increased levels of resistance to glycopeptide antibiotics were shown to contain additional serine in place of glycine in interpeptide chains of the peptidoglycan (5). The presence of epr inducing similar changes in amino acid content in peptidoglycan struc -FIG. 3 . Peptidoglycan amino compound composition of S. capitis EPK1 (EPK1), its derived strain without epr (EPK2), S. aureus RN4220 (TF1), and S. aureus RN4220 with epr (TF6). The amount of each compound is expressed as a molar ratio relative to glutamic acid (Glu). Gly, glycine; Ser, serine; Ala, alanine; Lys, lysine; Glu, glutamic acid; Mur, muramic acid; Glc, glucosamine. a The susceptibilities of heat-inactivated staphylococcal cells (COL, TF1, or TF8) to the bacteriolytic enzymes lysostaphin, 62-kDa AM, and 51-kDa GL were tested by zymography as described in Materials and Methods. After electrophoresis, the gels were washed with distilled water for 30 min and incubated at 37°C in 0.1 M sodium phosphate buffer (pH 6.8). After a 12-h incubation, the minimal concentration that showed a visible band was defined as the MBD. ture in S. aureus suggested that epr might affect the susceptibility of S. aureus to methicillin and/or vancomycin. MRSA strain COL (27) was transformed with pGC2 and pTFS6 to generate TF9 and TF10, respectively. MSSA (TF1 and TF8) and MRSA (TF9 and TF10) strains were tested for susceptibilities to methicillin and vancomycin. No differences were found in sensitivities to methicillin and vancomycin between the strains with epr and the corresponding strains without epr (Table 1) . Resistance levels of TF9 and TF10 to methicillin were further assessed by population analysis, and no differences were found between them (not shown). We next tried to determine whether epr is able to complement methicillin resistance of femA and femB MRSA mutants. MRSA strain BB270 and its femA and femB mutants, BB308 and UT-34-2, were transformed with either pGC2 or pTFS6. Transformants were tested for susceptibilities to methicillin and lysostaphin. As shown in Table 1 , we confirmed that femA and femB mutants were more resistant to lysostaphin than the parent strain BB270, although their resistance levels were much lower than that of S. aureus with epr on multicopy plasmid pGC2. In the presence of epr, the femA mutant became highly resistant to lysostaphin and partially restored its resistance to methicillin compared with TF13. This effect was markedly apparent after 48 h of incubation, probably due to the relatively slow growth of the transformants. In contrast, the femB mutant with epr became highly resistant to lysostaphin but maintained its sensitivity to methicillin.
DISCUSSION
Several mechanisms have been proposed for the resistance of cell wall peptidoglycan to peptidoglycan hydrolases. For example, O acetylation or unacetylation of amino sugars in peptidoglycan makes the cells resistant to lysozyme and other peptidoglycan hydrolases (1, 7, 12, 15, 29, 37, 56) . Accessory cell wall polymers, such as lipoteichoic acid (4, 8, 13, 20, 21) , teichoic acid (14, 59) , and teichuronic acid (36) , are implicated as endogenous inhibitors of peptidoglycan hydrolases and are suggested to protect peptidoglycan by associating with peptidoglycan hydrolases. In S. simulans bv. staphylolyticus, modification of the amino acid composition in peptidoglycan interpeptide chains was found to confer on the cells resistance to its product, lysostaphin (9, 35) , and the genetic element involved in this modification was designated epr (9) . Possibilities of involvement of additional polymers, such as teichoic acid or lipoteichoic acid, and acetyl moieties of the amino sugars in lysostaphin resistance were excluded (9) . By analogy, we suggest that the alteration of the amino acid composition in peptidoglycan interpeptide chains of S. capitis EPK1 confers on the cells resistance to ALE-1. The mechanism of this resistance appears to be specific for glycylglycine endopeptidase since the susceptibilities of cells to bacteriolytic enzymes with different bond specificities were not affected by the presence of epr (Table 3) .
Protein homology search revealed that the deduced amino acid sequence of the epr gene of S. capitis EPK1 is similar to that of femAB of S. aureus. Since matching amino acid residues are distributed all over the molecule, they seem to be derived from a common ancestal gene. Although they have amino acid sequence similarities, their functions appear to contrast. In staphylococcal strains with epr on a multicopy plasmid, serine content was increased and glycine content was decreased in peptidoglycan interpeptide chains. On the other hand, in S. aureus strains with inactivated femA or femB, glycine content was decreased in peptidoglycan interpeptide chains (3, 19, 26, 30, 48) . In S. aureus, the pentaglycine chain is introduced by sequential addition of glycine from Gly-tRNA to the ε-amino group of the L-lysine residue of the pentapeptide in the lipidlinked intermediate (23, 31, 57) . This process does not require ribosome and is distinct from protein synthesis in which amino acids are added at the carboxyl terminus. In S. epidermidis, interpeptide chains contain glycine and L-serine with a characteristic that the initial substituent of the ε-amino group of the L-lysine residue is glycine (58) . The two are transferred from Gly-tRNA and Ser-tRNA, respectively (33, 58) . Detailed analysis of the peptidoglycan structure of a femA mutant revealed an accumulation of mono-glycyl-substituted muropeptide and several species of muropeptides with substitution by serine in the second or fourth positions of the interpeptide chains (10) . This result suggested that the biosynthetic block in the femA mutant occurs after the addition of the first glycine residue to the interpeptide chain. Further studies suggested that femA is involved in the addition of second and third glycines to the first glycine, and femB is involved in the addition of fourth and fifth glycines, of the interpeptide pentaglycine chain of the peptidoglycan precursor (26, 48) . Our results suggest that gene products of femAB and epr belong to a protein family involved in adding amino acids to the pentapeptide peptidoglycan precursor and that epr is involved in adding serine to the pen- tapeptide. Further studies are clearly required to elucidate the exact biochemical functions of these proteins.
Southern hybridization analysis revealed that most of the coagulase-negative staphylococci tested possess epr sequences or sequences similar to that of epr. An unexpected finding was that S. aureus possesses a DNA fragment hybridizing with epr. It is not likely that this fragment contains femAB since a DNA fragment containing femAB did not hybridize with epr under the same experimental conditions (Fig. 4) . In some transposon mutants of femA, a decrease in glycine content was accompanied by a slight increase in serine content of interpeptide bridges (10) . The presence of serine in the interpeptide bridges of some S. aureus strains has been reported (44) . S. aureus might contain an epr homolog, the expression of which is somehow suppressed under normal growth conditions.
Unlike the femA or femB mutant of MRSA, MRSA with epr did not show a lowered resistance to methicillin (Table 1) . S. aureus with epr showed no change in vancomycin MIC (Table  1 ). These findings suggest that the alteration in amino acid composition (i.e., increase in serine content and decrease in glycine content) is not the direct cause of alteration in susceptibility of S. aureus to methicillin or vancomycin. It should be noted that the sum of glycine and serine contents in femA and femB mutants was much lower than that of the parent strain (10, 19, 26, 30, 48) . On the other hand, the sum of glycine and serine contents in S. aureus expressing epr was constant, about 5 mol per mol of glutamic acid (Fig. 3) . These results suggest that shortening of interpeptide bridges is an important factor in lowering the susceptibilities of MRSA to methicillin and affects peptidoglycan cross-linking and cell wall turnover. Complementation experiments of femA and femB mutants with epr suggest that epr has a functional relationship to femA in regard to methicillin resistance (Table 1) .
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ADDENDUM IN PROOF
Recently, it has been reported that Staphylococcus simulans bv. staphylolyticus possesses the lif gene, which is located in the opposite direction to that of the lysostaphin gene (G. Thumm and F. Götz Mol. Microbiol. 23:1251-1265, 1997) . The expression of lif in S. carnosus led to an increase in the serine/glycine ratio of the interpeptide bridges of peptidoglycan.
